BRKR.US Bruker Corporation

Healthcare Life Sciences Tools & Services USA Stocks
61.59 USD
Close of Nov 14, 2026
32.27 68.98
Market cap
USD 9.41B
P/E
-
P/B
4.03x
ROE
-8.7%
Dividend yield
0.24%
Fundamental score
-

Ratios use the latest price and the current fiscal year annualized from 3 quarters up to Sep 2026.

Is BRKR.US undervalued?

Graham number

The Graham number of Bruker Corporation cannot be estimated reliably (it needs positive earnings and book value).

Graham number = √(22.5 × EPS × book value per share): the most a defensive investor should pay according to Benjamin Graham. An estimate, not a recommendation to buy or sell. How is it calculated?

Bruker Corporation fundamental analysis

No fundamental analysis for Bruker Corporation yet.

Bruker Corporation stock price

Prices on the chart can differ slightly from the closing prices StockSummer uses for its ratios.

About Bruker Corporation

Bruker Corporation, together with its subsidiaries, develops, manufactures, and distributes scientific instruments, and analytical and diagnostic solutions. It operates through four segments: Bruker Scientific Instruments (BSI) BioSpin, BSI CALID, BSI Nano, and Bruker Energy & Supercon Technologies. The company offers magnetic resonance spectroscop, preclinical imaging, biopharma and applied, services and lifecycle support, integrated data solution, and automation; life scie…

Full company profile